140 likes | 158 Views
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies. Kidney Transplantation Committee Richard Formica, MD (Chair). Strategic Plan. The Problem. Relatively low match success rate in OPTN KPD program
E N D
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies Kidney Transplantation Committee Richard Formica, MD (Chair)
The Problem • Relatively low match success rate in OPTN KPD program • Antibody related issues and positive crossmatches continue to account for a significant number of match failures • Insufficient histocompatibility testing requirements to prevent match failure
Proposed: HLA Typing • Full list of HLA types must be reported on KPD donors • List of HLA types required for all candidates consistent with those for DD kidney policy • If candidate has unacceptable antigens, the corresponding HLA type must be reported • Molecular HLA typing required for candidates • Candidate’s hospital must retype donor to confirm HLA type
Proposed: Antibody Screenings • Candidate’s transplant hospital must screen all KPD candidates for antibodies: • every 90 days (+/- 20 days) • when potentially sensitizing event occurs • if candidate reactivated after more than 90 inactive days • if unacceptable positive crossmatch occurs that prevents transplant with matched donor • Physician/surgeon (or designee) and lab director (or designee) must review UAs listed for candidate before their first match run.
Proposed: Crossmatching Candidate’s transplant hospital must: • perform physical crossmatch before donor’s nephrectomy is scheduled and final crossmatch prior to transplant • report crossmatch results to donor’s transplant hospital and UNOS • report a reason for unacceptable positive crossmatch within 7 days If unacceptable positive crossmatch occurs that breaks the chain, UNOS will make candidate ineligible before next match run. Candidate will be eligible once candidate’s program reports that a review of UAs is complete.
Overall Project Impact 1,650/10,680 2290/17,885
Resolution 21 (page 79) RESOLVED, that additions and modifications to Policies 13: (Kidney Paired Donation (KPD)); 13.5 (Histocompatibility Testing); 13.6 (Matching within the OPTN KPD Program); 13.7 (KPD Screening Criteria); and 13.10 (Crossmatching Protocol), as set forth on page 79, are hereby approved, effective pending programming and notice to the OPTN membership.